@BranzaGigi @DavidLMayhew Dr Mayhew literally posted the study you requested. In order to get FDA approval, this is what is required. Here’s another one. https://t.co/hmsgPe2y1K https://t.co/nFAlkQv5qg
RT @oneadds: Right yeah but after you have got someone to design your poison you still have to get it through Clinical trials.. No problem…
Right yeah but after you have got someone to design your poison you still have to get it through Clinical trials.. No problem.. Just fund them!! https://t.co/LepU8i0U8x https://t.co/kAPTp1lxmn, https://t.co/kAPTp1lxmn https://t.co/QLsQfYoNjY https://t.co
@RUSElive @DrMcFillin “Participants were randomly assigned to receive either the ChAdOx1 nCoV-19 vaccine or the quadrivalent MenACWY protein-polysaccharide conjugate vaccine. MenACWY was used as a comparator vaccine rather than a saline placebo…..” 👀 http
👆️引用🔗の関連かな?👇️ 📝Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial Maheshi N Ramasamy et al. Lancet. 2021. https://t.co/bp30c
@MarKes1900 @krizzelfizzel @PaulSchuurmans1 @Celine_student Bij dit onderzoek MenACYW werd als placebovaccin gebruikt en kreeg de te testen groep AstraZeneca voor Corona. https://t.co/XKcIWioKtG https://t.co/zttvubEl5l
RT @gorka_orive: Resultados del ensayo clínico fase II de la candidata a vacuna ChAdOx1 nCoV-19 de Oxford/AstraZeneca. Buen perfil de segur…
@Mr_Magoo5 @WestsydeServer @IvorMectin1 @SwordtheChemist Ok here is the original Astra Zeneca study in which the second dose is referred to as a boost dose. https://t.co/lnwHIf8K72
@liliaragnar Da Ebola in poi gli adenovirus di simpanzè sono stati la base di studio per l'elaborazione di vaccini e fonte di ricerca in numerosi biolaboratori situati "chissadove" https://t.co/lfzzJRk0o0 https://t.co/54uch8HElR
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. https://t.co/2TFsmBdDOo
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults … https://t.co/jPyxJOYG0w
@edwin_latham (Efficacy of COVID Vaccines) - https://t.co/GYE4LJbFiY - https://t.co/hz9YCP8o15 - https://t.co/R0lHzRfj2w - https://t.co/KTHSf0kbaA - https://t.co/KTHSf0kbaA - https://t.co/iitcxtovQO - https://t.co/LktHbAxh00 - https://t.co/rwoJry4MKO - htt
@bad_bec Safety and efficacy (mRNA and adeno) - https://t.co/GYE4LJbFiY - https://t.co/hz9YCP8o15 - https://t.co/R0lHzRfj2w - https://t.co/KTHSf0kbaA - https://t.co/KTHSf0kbaA - https://t.co/iitcxtovQO - https://t.co/LktHbAxh00 - https://t.co/c5zgt0xQH6 (P
https://t.co/FwUSSMlIAt So ASTRAZENECA takes a meningococcal(Meningococci are bacteria) vaccine🔽 in the control/placebo group – so you can also falsify studies.... it's all a big crime!!! https://t.co/BK03JyLQz1
@ZubyMusic They’ve been talking from both sides of their mouths for ages. Just look at these few tweets to see how Hancock was purposefully twisting language to deceive re the vaccine’s function almost exactly 1 year ago:
@Laura_12154245 @beezi_janet @Morvern_C_ @CRY_UK The vaccine trial data is so "embargoed until 2076" that they started publishing it in err.....2020. FFS https://t.co/3pXtakv2mr
#COVID19 vaccines are not only safe and effective, they open the way to a future without this pandemic. The same future these #MelbourneProtest #FreedomRally think they pester for. #ScottyFromQAnon and #antivax allies want you to believe on scant evidence
@mschade72 @JosephArmand1 @AssivasElse Safety and efficacy (mRNA and adeno) - https://t.co/gJa2Da3rlu - https://t.co/hz9YCP8o15 - https://t.co/phtI0XkQH6 - https://t.co/NkSaMH6F4R - https://t.co/NkSaMH6F4R - https://t.co/etTtZ3fYY3 - https://t.co/jEkVi21Br
@R__sotol @RickArdoAO @rod_herrera https://t.co/9fUVKiumci Acá seguridad de AZ https://t.co/NM6BU6W1vF Esdudio fase 3 https://t.co/VjuU3oQYMb Seguridad de Sinovac, todos revisados y aprobados x pares.
RT @drantonioquispe: "Sinopharm: Segura e inmunogénica" En Sep-2021, en su ECCA fase 1-2 (n=288), reportó que un régimen de 3 dosis (2 μg,…
RT @drantonioquispe: "Sinopharm: Segura e inmunogénica" En Sep-2021, en su ECCA fase 1-2 (n=288), reportó que un régimen de 3 dosis (2 μg,…
"Sinopharm: Segura e inmunogénica" En Sep-2021, en su ECCA fase 1-2 (n=288), reportó que un régimen de 3 dosis (2 μg, 4 μg y 8 μg) de BBIBP-CorV tenía un perfil de seguridad aceptable y era capaz de provocar una fuerte respuesta humoral vs. SARS-CoV-2 ht
@ClaireHaddon2 If you've a supply of water, a day or so of comfort food, + a thermometer you're likely prepped for common side-effects (bit achy & a temperature for a day or so). Peer reviewed papers & details below - it is a minority so hopefully
@snj_1970 @ShamezLadhani @mrstevenjones1 Here’s the Oxford(AZ) phase 2 results based on dosing. It include single and prime-boost options and SD/SD and LD/LD. It wasn’t designed to show non-inferiority and might be under powered for that, but looks like th
打っとけ、という意見のエビデンス。Systematic reviewとRCTsを主に。 https://t.co/L2nVV5Hzbh https://t.co/tfoTAnrNt0 https://t.co/R10vwGlR2y https://t.co/6GIQZ8Mmy7
@peeoa36 https://t.co/UcnKDmrLSf ลง lancet ka มีตารางse อยู่ค่ะ
@sci_questions @Virusnerdette @macroliter More data are buried somewhere in this the apendix of this publication I guess, but can't find the quickly https://t.co/6aCNOZ44dg https://t.co/kwidzu5qL1
RT @carpe_diem0820: プレスリリースの論文化 アストラゼネカの開発するワクチンは高齢者で認容性高く高抗原用量のワクチン接種での免疫原性は全ての年齢群で同様 Safety and immunogenicity of ChAdOx1 nCoV-19 vaccin…
RT @nbonneel: - Pfizer: https://t.co/9li8qL0yLT : 22k vacc, 22k placebo, suivi médian de 2 mois. 2 morts vaccinés non liés au vac, 4 avec p…
RT @nbonneel: - Pfizer: https://t.co/9li8qL0yLT : 22k vacc, 22k placebo, suivi médian de 2 mois. 2 morts vaccinés non liés au vac, 4 avec p…
RT @nbonneel: - Pfizer: https://t.co/9li8qL0yLT : 22k vacc, 22k placebo, suivi médian de 2 mois. 2 morts vaccinés non liés au vac, 4 avec p…
RT @nbonneel: - Pfizer: https://t.co/9li8qL0yLT : 22k vacc, 22k placebo, suivi médian de 2 mois. 2 morts vaccinés non liés au vac, 4 avec p…
RT @nbonneel: - Pfizer: https://t.co/9li8qL0yLT : 22k vacc, 22k placebo, suivi médian de 2 mois. 2 morts vaccinés non liés au vac, 4 avec p…
- Pfizer: https://t.co/9li8qL0yLT : 22k vacc, 22k placebo, suivi médian de 2 mois. 2 morts vaccinés non liés au vac, 4 avec placebo. - Astrazeneca: https://t.co/g4JzarRsOX : 24k vacc ; le suivi rapporte sur 6k vacc+6k placebo. 1 mort vacciné non lié au vac
RT @benp7777: @maccheeky1 for 18-55 years olds, adverse reactions are high in number https://t.co/GRgHZ7JprW
RT @benp7777: @maccheeky1 for 18-55 years olds, adverse reactions are high in number https://t.co/GRgHZ7JprW
@RichardfromSyd1 @ms_dzt I think phase 2/3 trial but essentially old data https://t.co/SK2YQAxLGC
@aqualexh @crplto @ArianaGrande Peer reviewed papers showing common AstraZeneca & Pfizer side effects ⬇️ (basically if you're prepped for two days of feeling feverish you'll be OK - have water & comfort food to hand). If fear is of getting COVID -
@ServiceGenteng Semua vaksin Covid yg beredar sekarang tetap melewati fase pre-clinical ke hewan kok https://t.co/M3cygMGABB
@AntzWeb @MattHancock I’ll never forget the little weasel.
@Matt_Burlington @angelaissa66 What an absurd thing to say. As if everyone on twitter is working in a vaccination centre but , better yet heres lots of science about the Astrazeneca one. from the Lancet... since your bad faith request implies no info sh
@Ryan_Mac_Phd @angie_rasmussen Pro-vaccine but I favour telling people: common side effects (not rare 1 in 10,000 or less ones) if one gets them last a few days & COVID is weeks. Here are details:- Pfizer https://t.co/4RWgpgMJYz AstraZeneca (which has
@Sukyspook @petemorristwit Hancock was doing his best to avoid even acknowledging the lack of evidence in this regard too, so I imagine it’s come from the top? The word games they play switching between coronavirus and covid are sickening in that regard, i
@AnnadeBuisseret @IainMulady @BreezerGalway @Crestavernonfr1 @Chrissy_2697 They've been reviewed by regulatory agencies and the NDA documents are in the public domain. The AZ vaccine also has a wider journal publication. Only collection of long-term durati
Por ejemplo, si revisan la publicación de Folegatti y colaboradores en Lancet (2020; https://t.co/Tk9E6OwDsk) donde describen los resultados de la vacuna Astrazeneca, verán que se basaron en la información genética de la secuencia MN908946...
@pelagicbird @CiesekSandra @Sander_Lab @CarstenWatzl Ah, gefunden https://t.co/xhemYH16Y2. Ich ändere das im Artikel. Danke auch an Sie, @Sander_Lab
@MasalaBai No, I get it checked out by a doctor ASAP. This peer reviewed literature on Oxford vaccine (like Covishield) https://t.co/2fIidM3Uu4 - see fig 3 headache is common but dizziness - no. Rare but very serious - need to exclude CSVT https://t.co/Mz7
@emili77ps @DrCKambourian Lea. https://t.co/I6V8k8NWKz - AstraZeneca si tiene evidencia que pasa con 2da a los 3 meses https://t.co/y61g817Q4p
A estas alturas, creo, ya es obvio que la vacuna de Astra-Zeneca provoca efectos *pasajeros*, pero muy evidentes en menores de 55 años [artículo de The Lancet: https://t.co/P55npkHSmF ] Una guía *oficial* de recomendaciones después de esa vacuna no estaría
Et pour ChAdOx1 nCoV-19 https://t.co/iZv7Sj9Tb9
RT @MarkPlackett1: @zeroxcliche 4/ Approval is based on data collection I suggest biased collection (thread) https://t.co/SK2YQAxLGC
@zeroxcliche 4/ Approval is based on data collection I suggest biased collection (thread) https://t.co/SK2YQAxLGC
https://t.co/Jtkv3adikl bec the vaccine for the elders different than rest and differnt than children for all firms and more on protine terms but problems can still be exist over long term and mostly the sudden death
@refluxyz آسترازنکایی که تا امروز تزریق شده از طریق کووکس تامین شده و در نتیجه شکی نیست که استانداردها رو پاس کرده بوده. استرازنکا اصولن عوارض معمولی که ایجاد میکنه در جوانها شدیدتر از افراد مسن هست: https://t.co/1KkYTozGwS
@AniRubulotta @DrCKambourian Xq tanto odio!? Con 1 dosis tiene más del 70% de eficacia contra el contagio y el 99% de protección contra una forma grave. https://t.co/ZJ9TELlNgG La tasa de fallecidos con 1 sola dosis es mínima (0,0005%) Xq permitís la inoc
Parece que cerca de 80% das pessoas que tomaram a vacina de Oxford tiveram sintomas adversos, por causa do vetor viral vivo. Ela é mais bem tolerada em pessoas mais velhas que em jovens. No geral, em dois dias passa tudo. #VacinaParaTodos Fonte: https://t
@_LamNam_ @JamesWard73 @Coronavirusgoo1 Quoted tweet links to study with little graphs showing day by day side-effects for AZ (so you can see if your symptoms were different/worse than normal). As others said:- blood clot risk is very low but is I think sp
Fuentes ⛲ 1️⃣ https://t.co/LAKZ1V926j 2️⃣ https://t.co/lsvfrc335P 3️⃣ https://t.co/96l2MwQsuE 4️⃣ https://t.co/qYTfb7yGU4 5️⃣ https://t.co/3viaL3SLJo 6️⃣ https://t.co/8fQWJUhhRz 7️⃣ https://t.co/K5TqHpD0iT 13/13 #SARSCoV2 #COVID19 #Inmunología
@ramakumarr Great thread again. With reference to 7, immunogenicity data for Az's ChAdOx1 (which in India is Covishield) was published for all age groups (young adults came earlier) in December 2020 in the Lancet. https://t.co/837y0SudfF
@chimenesuleyman For anyone who wants to see the peer-reviewed published data on this: https://t.co/86jBeJXIlr
@jwoodgett @fordnation Agreed! My weekly whine & wine with current & ret’d 👩🏼🔬👩🏻🔬👩🏽🔬 profs, including immunologists & cell biologists who study #SARSCoV2, is also a journal club: Safety & immunogenicity of ChAdOx1 nCoV-19 💉: a single-bli
@Ahmedkhamis27 https://t.co/r6inmjafSa Please find attached the Lancet article. Enjoy the read
RT @Vigneo: 7) Lo que sí es cierto es que existe una clara tolerabilidad dependiente de la edad para la vacuna de AZ. Tiene mejor perfil de…
RT @Vigneo: 7) Lo que sí es cierto es que existe una clara tolerabilidad dependiente de la edad para la vacuna de AZ. Tiene mejor perfil de…
7) Lo que sí es cierto es que existe una clara tolerabilidad dependiente de la edad para la vacuna de AZ. Tiene mejor perfil de seguridad en mayores de 60 años. (Imagen) A pesar de ello, la frecuencia de los EA es muy baja. 🔗📑https://t.co/GHKvSHOIT0 http
@Srivida @sknatesm @GunasekaranMu https://t.co/SAWKNc7QNe . The original data similar. All vaccines take time to elicit an antibody response. You are correct before your antibodies are adequate you can get infected and sick. You can get infected even after
@triketora Fab. You've probably seen the Lancet (AZ) & NEJM (Pfizer) papers on common side-effects but if not they are linked below (Lancet has cool little "day by day" bar charts): https://t.co/86jBeJXIlr
RT @MarkPlackett1: @KerryWo46033782 @ProfMakris My thoughts on the AZ Chadox1 trial I maintain that the bias was innate in the design and d…
I found this from the lancet but when i look back at the vid, that looks way less than even 0.22 mL? Please explain. https://t.co/FdchF0VM0i https://t.co/fiwabCYQwt
@KerryWo46033782 @ProfMakris My thoughts on the AZ Chadox1 trial I maintain that the bias was innate in the design and data collection was inconsistent. We miss what we don't investigate the appendices are critical https://t.co/SK2YQAxLGC
@Ben_garrod If AstraZeneca/Oxford vaccine - figure 3 in this peer reviewed paper has nice little day by day of side-effects (for first dose one might get a whole range of effects and feel ill for a day or two - better than fortnight of COVID-19) https://t.
@Pignottone @MessoraClaudio @rokko50 @byoblu Eccone un altro https://t.co/WeeU2qaYFE
RT @konstantinospo7: Dear Editor, @TheLancet, Ramasamy et al. report an important medical event (pneumonia) and a limb ischemia, which are…
@DanielBayley80 Leopards/spots and all that. The word games have been there from the start.
@pelagicbird @Florian83616025 Zumindest bei ChAdOx1 scheint das nicht der Fall zu sein, die Antikörper steigen nach Tag 28 nicht weiter (https://t.co/rKFvmGCWPI). Konnte daran liegen, dass vor allem (nur?) Spike Protein exprimiert wird und damit in wesent
RT @konstantinospo7: Dear Editor, @TheLancet, Ramasamy et al. report an important medical event (pneumonia) and a limb ischemia, which are…
RT @konstantinospo7: Dear Editor, @TheLancet, Ramasamy et al. report an important medical event (pneumonia) and a limb ischemia, which are…
RT @konstantinospo7: Dear Editor, @TheLancet, Ramasamy et al. report an important medical event (pneumonia) and a limb ischemia, which are…
RT @konstantinospo7: Dear Editor, @TheLancet, Ramasamy et al. report an important medical event (pneumonia) and a limb ischemia, which are…
RT @konstantinospo7: Dear Editor, @TheLancet, Ramasamy et al. report an important medical event (pneumonia) and a limb ischemia, which are…
Dear Editor, @TheLancet, Ramasamy et al. report an important medical event (pneumonia) and a limb ischemia, which are characterized as not related to the vaccine. All these findings deserve further consideration Editor: .......... https://t.co/PUqp1cuNKX
Interesting results, in line with what was published from the clinical trial. The younger group tended to have more adverse events than the older groups. https://t.co/43wkzlFdcs https://t.co/hy1h0zs4XC
@winniemli This is peer reviewed article on that https://t.co/2fIidM3Uu4 (Figure 3 I think is where the nice little day by day graphs are). Good news is if 1st dose is just tiring for you (rather than fever & rest of side-effects) then 2nd dose shoul
@giganterodrigo_ @leosbastos @aseguirniteroi No estudo de fase 2 (segurança e imunogenicidade) dá pra ver uma pequena % maior em faixas etárias mais jovens, para alguns parâmetros https://t.co/6OuGvRAjDT
@Bannisterious @mn_me @PeterHotez Good grief, you serious? All the peer-reviewed papers on the vaccine studies have been published (example below), also the IND/NDA docs for regulatory review. As have the summaries of the regulatory reviews. As have the po
7) The side effects for the AstraZeneca vaccine, dose 1, are thus much lower than those reported in the Phase 3 trial: 33.7 vs 65-86% in their phase 2-3 trial. https://t.co/HRed0ULm0o
@LiliGar68864031 Pues claro que lo hay 🤣🤣🤣. Solo tienes que buscar en google, hombre. Por ejemplo, esto 👇🏼👇🏼 https://t.co/teCKpqoje1